CNX Therapeutics | B Corp™ Certified
Director, Business Development

How your CV stacks up
Upload your CV to see how well it fits this job role
?%
Director, Business Development
Purpose of the Position
The Director, Business Development will play a central leadership role in shaping CNX Therapeutics’ long‑term growth strategy through oversight of pipeline development, in‑licensing activities, and strategic external partnerships.
Operating as a senior member of the Corporate Development function, the Director will lead the identification, evaluation, and execution of high‑value business development opportunities that support CNX’s corporate objectives across Europe and beyond.
This role carries significant strategic and commercial ownership, with responsibility for steering cross‑functional decision‑making, informing investment priorities, advising the Leadership Team, and representing CNX Therapeutics externally at the highest levels.
Core Tasks & Responsibilities
Strategic Leadership & Portfolio Direction
Lead CNX Therapeutics’ overall in‑licensing and partnership strategy, ensuring alignment with corporate growth priorities Drive strategic portfolio planning through rigorous market, competitive, and portfolio assessment in partnership with Strategic planning and portfolio. Provide senior leadership input into long‑range planning, investment decisions, and corporate development roadmaps Advise the Corporate Development team, Leadership Team, and Board‑level stakeholders on strategic opportunities
Origination & Pipeline
Maintain an active view of the European specialty pharma licensing market- available assets, active divestiture programmes, and emerging partnership opportunities Build and manage proactively an active pipeline of in-licensing opportunities- branded products, reformulations, line extensions, and late-stage development assets across Europe and relevant global regions. Identify and approach potential licensors directly: large pharma tail asset programmes, mid-size specialty companies, and emerging European biotech Build strong executive‑level relationships with pharmaceutical companies, developers, CMOs, dossier develops, brokers and industry partners
Reasons to use Rodeo
I’m in my final year doing Economics and I don’t know whether to apply for grad schemes now or do a masters first. What do you think?
Honest answer — it depends on where you want to end up. A lot of top grad schemes (Big 4, civil service, banking) don’t need a masters. Let’s look at the ones you’d be competitive for now, and we can decide if a masters actually adds anything.
Also worth knowing: most autumn 2026 applications are open now. Timing matters more than you think.
Start with a chat, not a search bar
Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.
Graduate Consultant — 2026 Scheme
Why you're a good match
StrongYour economics background and your summer at a regional bank line up with what PwC looks for on the consulting scheme. Applications close in four weeks.
See breakdownIt searches the market for you
Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.
Why you're a good match
You’ve got the grades and the economics background, and your bank internship is exactly the experience this scheme looks for. Apply soon — deadlines close within the month.
Experience fit
Your summer at the bank plus your econometrics coursework map directly to the day-one responsibilities on this scheme — client modelling, market briefings, and deal support.
Only hits
No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.
Deal Ownership and Cross‑Functional Leadership
Act as deal lead for BD transactions, guiding stakeholders from opportunity sourcing through execution. Lead diligence commercial assessment: market sizing, competitive dynamics, pricing/reimbursement landscape, regulatory pathway, and lifecycle potential Collaborate with Transaction Excellence and Finance for business cases, financial modelling, and risk‑opportunity assessments Chair cross‑functional workstreams (Regulatory, Medical, Supply Chain, Finance, Commercial) to ensure alignment on BD opportunities in tandem with Transaction Excellence. Serve as a senior decision‑maker in due‑diligence processes, guiding commercial assessment, regulatory strategy, pricing, and market access considerations Lead the development and negotiation of Heads of Terms and commercial contracts Provide governance oversight for new asset integration and contribute to launch and lifecycle planning.
Commercial and Distribution Partnerships
Originate and negotiate co-promotion, co-marketing, and commercial partnership agreements with regional specialty pharma operators across Europe Identify and contract distribution partners in markets where direct infrastructure is not justified Manage ongoing licensing and partnership relationships- milestones, performance, amendments, renewals
Out-Licensing and Asset Monetization
Identify portfolio products suitable for out-licensing in markets outside the CNX direct commercial footprint Manage out-licensing processes end-to-end- counterparty identification, terms negotiation, and execution in alignment with CNX End-to-End Corporate Development Processes (“E2E”) Structure out-licensing terms to protect core market interests and preserve re-acquisition optionality Support M&A team in case of major strategic out-licensing project


Get help with your application
Your very own career expert that helps elevate your application to the next level.
External Representation & Corporate Influence
Represent CNX Therapeutics as a senior corporate ambassador with partners, investors, and potential acquisition targets Promote CNX as the go to partner across the European Generics and Generics‑Plus market Influence external stakeholders to enhance CNX’s competitive and partnership position Model CNX Values and uphold the highest standards of ethics, governance, and compliance Champion ESG‑aligned decision‑making across business development activities
What Success Looks Like
Active in-licensing pipeline of 15–20 qualified product opportunities at any point in time 3–5 licensing or partnership agreements signed annually Growing proportion of deal flow sourced through direct outreach rather than intermediated channels Out-licensing generating incremental revenue in non-core geographies within 18 months
Essential
Required skills & experience
Extensive experience in the pharmaceutical industry Significant business development leadership experience Deep knowledge of the European Generics and/or Generics‑Plus market Proven experience in product pipeline development and commercial evaluation Strong regulatory, pricing, reimbursement, and market access understanding across EU markets Expertise in contract negotiation and deal structuring Advanced financial modelling capabilities Proficiency with market analysis tools Fluent in English
Desirable
Educated within Business or Life Sciences Pharmacy or medical qualification Experience evaluating differentiated product opportunities Additional European languages Experience within Private Equity environments
“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”
Jessica, London
Skills